International Assets Investment Management, LLC Aldeyra Therapeutics, Inc. Transaction History
International Assets Investment Management, LLC
- $1.2 Trillion
- Q4 2024
A detailed history of International Assets Investment Management, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, International Assets Investment Management, LLC holds 59,750 shares of ALDX stock, worth $287,995. This represents 0.03% of its overall portfolio holdings.
Number of Shares
59,750
Previous 287,287
79.2%
Holding current value
$287,995
Previous $53.3 Million
485.17%
% of portfolio
0.03%
Previous 0.15%
Shares
18 transactions
Others Institutions Holding ALDX
# of Institutions
116Shares Held
36.2MCall Options Held
196KPut Options Held
142K-
Perceptive Advisors LLC New York, NY9.28MShares$44.7 Million1.31% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$26.4 Million14.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$18.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$17.5 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.88MShares$9.07 Million0.24% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $281M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...